File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature

TitleBiphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature
Authors
Issue Date2006
Citation
Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO, 2006, v. 116, n. 10, p. 1035-1047 How to Cite?
AbstractIn recent years, a growing number of reports in the literature have linked osteonecrosis of the jaw bones with intravenously administered bisphosphonates prescribed for the treatment of hypercalcemia of malignancy due to bone lesions of multiple myeloma or bone metastases in patients with breast or prostate cancer. Furthermore, an association between chronic oral bisphosphonate use in patients with osteoporosis or Paget's disease, and bone necrosis in the mandible or maxilla has been demonstrated in numerous case reports and case series in the last couple of years. Therapeutically, osteonecrosis of the jaws seems to be difficult to treat surgically, often resulting in a recurring or even progressing lesion. In the present case report of a bisphosphonate-associated osteonecrosis of the maxilla in a patient with osteoporosis, the current literature will be discussed, and open research questions and potential problems for our daily dental practice routine will be addressed.
Persistent Identifierhttp://hdl.handle.net/10722/236110
ISSN

 

DC FieldValueLanguage
dc.contributor.authorBornstein, Michael M.-
dc.contributor.authorOberli, Kaspar-
dc.contributor.authorStauffer, Edouard-
dc.contributor.authorBuser, Daniel-
dc.date.accessioned2016-11-11T07:42:58Z-
dc.date.available2016-11-11T07:42:58Z-
dc.date.issued2006-
dc.identifier.citationSchweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO, 2006, v. 116, n. 10, p. 1035-1047-
dc.identifier.issn1011-4203-
dc.identifier.urihttp://hdl.handle.net/10722/236110-
dc.description.abstractIn recent years, a growing number of reports in the literature have linked osteonecrosis of the jaw bones with intravenously administered bisphosphonates prescribed for the treatment of hypercalcemia of malignancy due to bone lesions of multiple myeloma or bone metastases in patients with breast or prostate cancer. Furthermore, an association between chronic oral bisphosphonate use in patients with osteoporosis or Paget's disease, and bone necrosis in the mandible or maxilla has been demonstrated in numerous case reports and case series in the last couple of years. Therapeutically, osteonecrosis of the jaws seems to be difficult to treat surgically, often resulting in a recurring or even progressing lesion. In the present case report of a bisphosphonate-associated osteonecrosis of the maxilla in a patient with osteoporosis, the current literature will be discussed, and open research questions and potential problems for our daily dental practice routine will be addressed.-
dc.languageeng-
dc.relation.ispartofSchweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO-
dc.titleBiphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature-
dc.typeArticle-
dc.description.natureLink_to_subscribed_fulltext-
dc.identifier.pmid2006252016-
dc.identifier.scopuseid_2-s2.0-33750960159-
dc.identifier.volume116-
dc.identifier.issue10-
dc.identifier.spage1035-
dc.identifier.epage1047-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats